Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chanjun Lu"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Arteriovenous fistulas (AVFs) have long been used as dialysis access in patients with end-stage renal disease; however, their maturation and long-term patency still fall short of clinical needs. Rodent models are irreplaceable to facilitate the study
Externí odkaz:
https://doaj.org/article/f44228f743b143698e2fb958a86e0a3c
Autor:
Ke Hu, Yi Guo, Yuxuan Li, Shunchang Zhou, Chanjun Lu, Chuanqi Cai, Hongjun Yang, Yiqing Li, Weici Wang
Publikováno v:
Antioxidants, Vol 13, Iss 1, p 5 (2023)
(1) Background: Arteriovenous fistulas (AVFs) are the preferred site for hemodialysis. Unfortunately, approximately 60% of patients suffer from AVF failure within one year. Oxidative stress plays an important role in the occurrence and development of
Externí odkaz:
https://doaj.org/article/3a8636ea6db9473ca173c1dcf4fbf71d
Autor:
Ke Hu, Yi Guo, Yuxuan Li, Chanjun Lu, Chuanqi Cai, Shunchang Zhou, Zunxiang Ke, Yiqing Li, Weici Wang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
For more than half a century, arteriovenous fistula (AVFs) has been recognized as a lifeline for patients requiring hemodialysis (HD). With its higher long-term patency rate and lower probability of complications, AVF is strongly recommended by guide
Externí odkaz:
https://doaj.org/article/d4b07ee80ab24371a3811ef9f35f439e
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Recent advances in the pathophysiologic understanding of coronavirus disease 2019 (COVID-19) suggests that cytokine release syndrome (CRS) has an association with the severity of disease, which is characterized by increased tumor necrosis factor α (
Externí odkaz:
https://doaj.org/article/becd1c0a2f404f5383f99f237b5f7a56
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 1, p 3 (2022)
(1) Background: Arteriovenous fistulas (AVFs) are the preferred access for hemodialysis. Unfortunately, about 60% of patients, especially female patients, fail to receive normal dialysis within one year after surgery because of AVF failure. However,
Externí odkaz:
https://doaj.org/article/1fb3d25c053b45f39c3ab14e7e7faa1e
Publikováno v:
Biomolecules, Vol 12, Iss 3, p 390 (2022)
Cardiovascular diseases (CVDs) are still a major cause of global mortality and disability, seriously affecting people’s lives. Due to the severity and complexity of these diseases, it is important to find new regulatory mechanisms to treat CVDs. Fe
Externí odkaz:
https://doaj.org/article/a96c3d9f7e87421383b573e04c005422
Autor:
Ke, Hu, Yuxuan, Li, Zunxiang, Ke, Hongjun, Yang, Chanjun, Lu, Yiqing, Li, Yi, Guo, Weici, Wang
Publikováno v:
Biomaterials translational. 3(1)
Cardiovascular disease serves as the leading cause of death worldwide, with stenosis, occlusion, or severe dysfunction of blood vessels being its pathophysiological mechanism. Vascular replacement is the preferred surgical option for treating obstruc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99a1a0f6b3ff804a83023cf58b7a5831
https://pubmed.ncbi.nlm.nih.gov/35837341
https://pubmed.ncbi.nlm.nih.gov/35837341
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Recent advances in the pathophysiologic understanding of coronavirus disease 2019 (COVID-19) suggests that cytokine release syndrome (CRS) has an association with the severity of disease, which is characterized by increased tumor necrosis factor α (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69da4ae944a9dea4e539201030e4965
https://pubmed.ncbi.nlm.nih.gov/35223745
https://pubmed.ncbi.nlm.nih.gov/35223745